Cargando…
A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization
To overcome the ongoing COVID-19 pandemic, vaccination campaigns are the highest priority of majority of countries. Limited supply and worldwide disproportionate availability issues for the approved vaccines, together with concerns about rare side-effects have recently initiated the switch to hetero...
Autores principales: | Mattoo, Sameer-ul-Salam, Myoung, Jinjong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Microbiology and Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705928/ https://www.ncbi.nlm.nih.gov/pubmed/34949742 http://dx.doi.org/10.4014/jmb.2111.11026 |
Ejemplares similares
-
T cell responses to SARS-CoV-2 in humans and animals
por: Mattoo, Sameer-ul-Salam, et al.
Publicado: (2022) -
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin
por: Mattoo, Sameer-ul-Salam, et al.
Publicado: (2022) -
Heterologous COVID-19 vaccination as a strategy to accelerate mass immunization
por: Klastrup, Vibeke, et al.
Publicado: (2022) -
Two years of COVID-19 pandemic: where are we now?
por: Myoung, Jinjong
Publicado: (2022) -
Closer and closer? Maternal immunization: current promise, future horizons
por: Engmann, Cyril, et al.
Publicado: (2020)